Results 311 to 320 of about 333,660 (389)

A case of primary biliary cirrhosis complicated with hepatocellular carcinoma showing negative results for HCV, HBV and HGV markers.

, 1997
M. Ogura, Naoaki Hashimoto, Etsu Ohno, Yasushi Takeda, Reiko Dehari, Masashi Furuie, Takashi Sawatari, Kimihiko Akimoto, Hiroshi Matsuura, Kunji Mita, Hiroki Kawahara, Takeo Suzuki, T Korenaga, Yukiko Kishida, Kazuto Yamasaki, Kazuhiro Yakumaru, Hiroshi Osamura   +16 more
openalex   +2 more sources

Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics

HIV Medicine, EarlyView.
Abstract Objectives Long‐acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real‐world data in East Asia remain scarce. This study aims to evaluate the impact of CAB+RPV in people with HIV in Japan, focusing on virological outcomes, treatment continuation and inflammatory markers, providing valuable insight ...
Eisuke Adachi, Rumi Minami, Michinori Shirano, Hideta Nakamura, Kazuaki Fukushima, Mayumi Imahashi, Ryoko Sekiya, Yusuke Yoshino, Toshibumi Taniguchi, J‐HIV RWD Collaborative Database Team, Takashi Muramatsu, Yuji Hirai   +11 more
wiley   +1 more source

Prevalence and Correlates of Hepatitis B in Pregnancy: Evidence From a Cross-Sectional Study in Bono East Region, Ghana. [PDF]

Health Sci Rep
Bardoe D, Hayford D, Bio RB, Yar DD.
europepmc   +1 more source

Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities

HIV Medicine, EarlyView.
Abstract Objective People with HIV experience disparate access to solid organ transplantation (SOT), despite mounting evidence for comparable outcomes. This review aims to understand the outcomes following SOT, obstacles to SOT and opportunities to improve access and outcomes following SOT.
David W. J. Griffin, J. H. McMahon, D. A. Ruschena, J. F. Hoy   +3 more
wiley   +1 more source

Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance. [PDF]

Nat Commun
Harris JM, Lok J, Wand N, Magri A, Tsukuda S, Wu Y, Ng E, Jennings D, Elshenawy B, Balfe P, McKeating JA.   +10 more
europepmc   +1 more source

RESPONSE TO HBV-VACCINE IN PATIENTS TRANSPLANTED FOR HBV-RELATED LIVER DISEASE TREATED WITH HYPERIMMUNE GAMMAGLOBULIN

, 1999
Rafael Bárcena, R Fernández-Braso, Antonio López–Sanromán, María Paniagua García, Asunción Moreno, Marta Regodon Dominguez, N Moreno, Jesús Urmán   +7 more
openalex   +1 more source

Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the OPERA cohort

HIV Medicine, EarlyView.
Abstract Objectives To compare the virologic effectiveness and discontinuation of the commonly prescribed fixed‐dose combination 3‐drug and 2‐drug regimens, bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) and dolutegravir/lamivudine (DTG/3TC), in virologically suppressed individuals in routine clinical care in the US.
Gerald Pierone Jr, Laurence Brunet, Jennifer S. Fusco, Michael G. Sension, Megan S. Dunbar, Joshua Gruber, Douglas T. Dieterich, Gregory P. Fusco   +7 more
wiley   +1 more source

A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biology. [PDF]

MAbs
Khan S, Lum J, Stephenson H, Kohli PB, Mortenson D, Ramakrishnan D, Hung M, Ding S, Seto E, Lu S, Yen R, Jin D, Lee B, Clancy S, Oakdale NS, Novikov N, Kang D, Li R, Pan D, Dave R, Lansdon E, Fletcher SP, Garg AV, Thomsen N, Balsitis S.   +24 more
europepmc   +1 more source

Effective Combination Therapy with lamivudine and ganciclovir in recurrent HBV Infection after liver transplantation

, 1999
Nicola Speidel, Melanie Fiedler, R. Länge, C. E. Broelsch   +3 more
openalex   +1 more source

Intersections of vitamin D deficiency, HIV and chronic liver diseases

HIV Medicine, EarlyView.
Abstract Objectives Despite effective antiretroviral therapy (ART), chronic liver diseases remain a leading cause of morbidity and mortality among people with HIV, with metabolic dysfunction–associated steatotic liver disease (MASLD) now the predominant etiology. Vitamin D deficiency is also highly prevalent in this population.
Francesca Farina, Aurgho Datta, Suzanne N. Morin, Sahar Saeed, Bertrand Lebouche, Giovanni Guaraldi, Salvatore Petta, Giada Sebastiani   +7 more
wiley   +1 more source